Hydroxychloroquine use was evenly distributed across the United States, but outpatient use of ivermectin was significantly higher in southern states.
During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Health leaders from multiple prior administrations sound alarm over CDC cuts
- COVID-19 may put patients at risk for other infections for at least 1 year
- COVID-19 re-infection doubles risk of long COVID in kids, young adults, data reveal
- Healthcare workers with chronic condition miss more days of work due to COVID than flu, data show